US Stock MarketDetailed Quotes

Quantum BioPharma (QNTM)

Watchlist
  • 6.300
  • -0.120-1.87%
Close Jan 22 16:00 ET
24.21MMarket Cap-0.66P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quantum BioPharma (QNTM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
50.26%-1.72M
-221.38%-1.95M
-115.91%-4.26M
36.49%-6.88M
1.87%-835.76K
-102.08%-3.46M
82.72%-606.48K
58.49%-1.97M
60.18%-10.83M
86.54%-851.65K
Net income from continuing operations
-18.24%-4.75M
-191.31%-9.77M
-317.89%-8.74M
18.18%-14.92M
-230.37%-5.46M
-254.96%-4.02M
38.94%-3.35M
79.00%-2.09M
31.73%-18.23M
73.14%-1.65M
Operating gains losses
300.78%522.71K
5,204.64%8.74M
150.17%1.21M
54.29%-2.53M
46.18%-2.92M
-3,341.25%-260.34K
150.18%164.68K
133.89%484.04K
-1,990.05%-5.53M
-1,700.86%-5.42M
Depreciation and amortization
20.30%145.34K
3.34%141.38K
7.95%129.69K
-80.43%490.57K
-7.70%112.8K
-17.71%120.81K
-87.65%136.81K
-89.37%120.14K
-44.73%2.51M
-89.41%122.22K
Other non cash items
30.22%13.51K
1,015.68%93.24K
14,755.00%1.84M
-1.59%23.9K
-100.15%-7.24K
100.52%10.37K
100.29%8.36K
423.14%12.41K
-40.46%24.29K
4,719.31%4.94M
Change In working capital
244.75%2.13M
-146.57%-1.08M
151.09%284.21K
495.72%9.76M
926.00%7.37M
-46.04%618.21K
1,126.30%2.32M
-245,168.28%-556.31K
123.00%1.64M
145.67%718.33K
-Change in receivables
156.36%295.69K
-94.67%61.35K
-15.90%513.61K
719.87%4.52M
6,701.00%3.28M
-220.15%-524.65K
232.14%1.15M
349.13%610.74K
89.90%-728.72K
96.59%-49.7K
-Change in inventory
---753
--16.99K
--23.39K
---117.24K
---117.24K
--0
--0
--0
--0
----
-Change in prepaid assets
2,179.95%413.93K
-316.50%-308.88K
36.01%-75.31K
-72.73%86.38K
-57.87%81.29K
-112.90%-19.9K
-57.39%142.67K
67.79%-117.68K
-60.21%316.72K
-66.98%192.95K
-Change in payables and accrued expense
22.33%1.42M
-85.66%147.92K
83.09%-177.48K
108.33%4.27M
443.46%3.13M
109.60%1.16M
233.69%1.03M
-271.81%-1.05M
392.92%2.05M
--575.08K
-Change in other working capital
--0
----
----
--1M
----
----
----
----
----
----
Cash from discontinued investing activities
0
0
Operating cash flow
50.26%-1.72M
-221.38%-1.95M
-115.91%-4.26M
36.49%-6.88M
1.87%-835.76K
-102.08%-3.46M
82.72%-606.48K
58.49%-1.97M
61.79%-10.83M
86.54%-851.65K
Investing cash flow
Cash flow from continuing investing activities
111.79%408.42K
-284.41%-1.36M
-5,998.50%-1.35M
-457.74%-1.5M
1.24M
-1,184.78%-3.46M
738.22K
-22.14K
55.63%-269.58K
0
Net PPE purchase and sale
----
--85.72K
--268.29K
--0
----
----
--0
--0
--0
----
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Net business purchase and sale
----
----
----
--0
--0
----
----
----
--31.78K
--0
Net investment purchase and sale
111.79%408.42K
-284.41%-1.36M
-5,998.50%-1.35M
-398.92%-1.5M
--1.24M
-1,049.28%-3.46M
--738.22K
---22.14K
-23.72%-301.36K
--0
Cash from discontinued investing activities
Investing cash flow
111.79%408.42K
-284.41%-1.36M
-5,998.50%-1.35M
-457.74%-1.5M
--1.24M
-1,184.78%-3.46M
--738.22K
---22.14K
-102.22%-269.58K
--0
Financing cash flow
Cash flow from continuing financing activities
-96.12%261.43K
-30.09%1.29M
450.97%3.13M
471.61%11.62M
9,885.24%2.47M
12,400.66%6.74M
4,378.90%1.84M
118.94%568.72K
-51.09%-3.13M
49.10%-25.22K
Net issuance payments of debt
186.18%264.92K
147,699.16%1.93M
1,033.97%3.09M
601.58%948.25K
3,989.26%982.08K
-461.21%-307.41K
102.39%1.31K
601.31%272.28K
-32.14%-189.05K
49.03%-25.25K
Net common stock issuance
--0
-99.98%439
--0
460.76%10.67M
4,368,917.65%1.49M
--7.05M
--1.84M
110.02%296.44K
-53.55%-2.96M
--34
Proceeds from stock option exercised by employees
--0
--145.46K
--45.89K
--0
--0
--0
--0
--0
--20.25K
--0
Net other financing activities
---3.5K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-96.12%261.43K
-30.09%1.29M
450.97%3.13M
471.61%11.62M
9,885.24%2.47M
12,400.66%6.74M
4,378.90%1.84M
118.94%568.72K
-51.09%-3.13M
49.10%-25.22K
Net cash flow
Beginning cash position
-54.71%1.5M
164.49%3.52M
117.47%6M
-83.76%2.76M
-14.14%3.12M
-41.69%3.31M
-85.58%1.33M
-83.76%2.76M
-51.84%16.98M
-84.70%3.63M
Current changes in cash
-464.13%-1.05M
-202.24%-2.02M
-73.64%-2.48M
122.77%3.24M
427.94%2.88M
90.85%-186.42K
155.64%1.98M
81.61%-1.43M
22.19%-14.22M
87.04%-876.87K
End cash Position
-85.71%445.94K
-54.71%1.5M
164.49%3.52M
117.47%6M
117.47%6M
-14.14%3.12M
-41.69%3.31M
-85.58%1.33M
-83.76%2.76M
-83.76%2.76M
Free cash flow
50.26%-1.72M
-221.38%-1.95M
-115.91%-4.26M
36.49%-6.88M
1.87%-835.76K
-102.08%-3.46M
82.72%-606.48K
58.49%-1.97M
62.27%-10.83M
86.53%-851.65K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 50.26%-1.72M-221.38%-1.95M-115.91%-4.26M36.49%-6.88M1.87%-835.76K-102.08%-3.46M82.72%-606.48K58.49%-1.97M60.18%-10.83M86.54%-851.65K
Net income from continuing operations -18.24%-4.75M-191.31%-9.77M-317.89%-8.74M18.18%-14.92M-230.37%-5.46M-254.96%-4.02M38.94%-3.35M79.00%-2.09M31.73%-18.23M73.14%-1.65M
Operating gains losses 300.78%522.71K5,204.64%8.74M150.17%1.21M54.29%-2.53M46.18%-2.92M-3,341.25%-260.34K150.18%164.68K133.89%484.04K-1,990.05%-5.53M-1,700.86%-5.42M
Depreciation and amortization 20.30%145.34K3.34%141.38K7.95%129.69K-80.43%490.57K-7.70%112.8K-17.71%120.81K-87.65%136.81K-89.37%120.14K-44.73%2.51M-89.41%122.22K
Other non cash items 30.22%13.51K1,015.68%93.24K14,755.00%1.84M-1.59%23.9K-100.15%-7.24K100.52%10.37K100.29%8.36K423.14%12.41K-40.46%24.29K4,719.31%4.94M
Change In working capital 244.75%2.13M-146.57%-1.08M151.09%284.21K495.72%9.76M926.00%7.37M-46.04%618.21K1,126.30%2.32M-245,168.28%-556.31K123.00%1.64M145.67%718.33K
-Change in receivables 156.36%295.69K-94.67%61.35K-15.90%513.61K719.87%4.52M6,701.00%3.28M-220.15%-524.65K232.14%1.15M349.13%610.74K89.90%-728.72K96.59%-49.7K
-Change in inventory ---753--16.99K--23.39K---117.24K---117.24K--0--0--0--0----
-Change in prepaid assets 2,179.95%413.93K-316.50%-308.88K36.01%-75.31K-72.73%86.38K-57.87%81.29K-112.90%-19.9K-57.39%142.67K67.79%-117.68K-60.21%316.72K-66.98%192.95K
-Change in payables and accrued expense 22.33%1.42M-85.66%147.92K83.09%-177.48K108.33%4.27M443.46%3.13M109.60%1.16M233.69%1.03M-271.81%-1.05M392.92%2.05M--575.08K
-Change in other working capital --0----------1M------------------------
Cash from discontinued investing activities 00
Operating cash flow 50.26%-1.72M-221.38%-1.95M-115.91%-4.26M36.49%-6.88M1.87%-835.76K-102.08%-3.46M82.72%-606.48K58.49%-1.97M61.79%-10.83M86.54%-851.65K
Investing cash flow
Cash flow from continuing investing activities 111.79%408.42K-284.41%-1.36M-5,998.50%-1.35M-457.74%-1.5M1.24M-1,184.78%-3.46M738.22K-22.14K55.63%-269.58K0
Net PPE purchase and sale ------85.72K--268.29K--0----------0--0--0----
Net intangibles purchase and sale --------------0------------------0----
Net business purchase and sale --------------0--0--------------31.78K--0
Net investment purchase and sale 111.79%408.42K-284.41%-1.36M-5,998.50%-1.35M-398.92%-1.5M--1.24M-1,049.28%-3.46M--738.22K---22.14K-23.72%-301.36K--0
Cash from discontinued investing activities
Investing cash flow 111.79%408.42K-284.41%-1.36M-5,998.50%-1.35M-457.74%-1.5M--1.24M-1,184.78%-3.46M--738.22K---22.14K-102.22%-269.58K--0
Financing cash flow
Cash flow from continuing financing activities -96.12%261.43K-30.09%1.29M450.97%3.13M471.61%11.62M9,885.24%2.47M12,400.66%6.74M4,378.90%1.84M118.94%568.72K-51.09%-3.13M49.10%-25.22K
Net issuance payments of debt 186.18%264.92K147,699.16%1.93M1,033.97%3.09M601.58%948.25K3,989.26%982.08K-461.21%-307.41K102.39%1.31K601.31%272.28K-32.14%-189.05K49.03%-25.25K
Net common stock issuance --0-99.98%439--0460.76%10.67M4,368,917.65%1.49M--7.05M--1.84M110.02%296.44K-53.55%-2.96M--34
Proceeds from stock option exercised by employees --0--145.46K--45.89K--0--0--0--0--0--20.25K--0
Net other financing activities ---3.5K------------------------------------
Cash from discontinued financing activities
Financing cash flow -96.12%261.43K-30.09%1.29M450.97%3.13M471.61%11.62M9,885.24%2.47M12,400.66%6.74M4,378.90%1.84M118.94%568.72K-51.09%-3.13M49.10%-25.22K
Net cash flow
Beginning cash position -54.71%1.5M164.49%3.52M117.47%6M-83.76%2.76M-14.14%3.12M-41.69%3.31M-85.58%1.33M-83.76%2.76M-51.84%16.98M-84.70%3.63M
Current changes in cash -464.13%-1.05M-202.24%-2.02M-73.64%-2.48M122.77%3.24M427.94%2.88M90.85%-186.42K155.64%1.98M81.61%-1.43M22.19%-14.22M87.04%-876.87K
End cash Position -85.71%445.94K-54.71%1.5M164.49%3.52M117.47%6M117.47%6M-14.14%3.12M-41.69%3.31M-85.58%1.33M-83.76%2.76M-83.76%2.76M
Free cash flow 50.26%-1.72M-221.38%-1.95M-115.91%-4.26M36.49%-6.88M1.87%-835.76K-102.08%-3.46M82.72%-606.48K58.49%-1.97M62.27%-10.83M86.53%-851.65K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -